Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 4, 2014, Pages 546-554

  Pietzsch, Jan B ^a   Geisler, Benjamin P ^a   Garner, Abigail M ^a   Zeller, Thomas ^b   Jaff, Michael R ^c  

^a Wing Tech Inc   (United States)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

balloon; balloon angioplasty; drug coated eluting; drug eluting; economics cost effectiveness; endovascular intervention; peripheral arterial disease; stent

Indexed keywords

ARTICLE; BALLOON; BARE METAL STENT; BUDGET; CLINICAL EFFECTIVENESS; COST CONTROL; DRUG COATED BALLOON; DRUG ELUTING STENT; ECONOMIC EVALUATION; ENDOVASCULAR INTERVENTION; FEMORAL ARTERY; FEMOROPOPLITEAL ARTERIAL DISEASE; GERMANY; HUMAN; MEDICARE; NONSURGICAL INVASIVE THERAPY; NUMBERS NEEDED TO TREAT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; REIMBURSEMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNITED STATES; ADVERSE EFFECTS; CENTRAL VENOUS CATHETER; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DEVICES; DRUG COST; ECONOMICS; HEALTH CARE COST; PERIPHERAL ARTERIAL DISEASE; PROBABILITY; STATISTICAL MODEL; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TREATMENT OUTCOME;

BIOMATERIAL; CARDIOVASCULAR AGENT; METAL;

ANGIOPLASTY, BALLOON; BUDGETS; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG COSTS; DRUG-ELUTING STENTS; FEMORAL ARTERY; GERMANY; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MARKOV CHAINS; MEDICARE; METALS; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; STENTS; TREATMENT OUTCOME; UNITED STATES; VASCULAR ACCESS DEVICES;

EID: 84908196442     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25536     Document Type: Article

References (25)

1. Inglis SC, Lewsey JD, Lowe GD, Jhund P, Gillies M, Stewart S, et al. Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: Impact on general and mental health, quality of life and five-year mortality. Int J Cardiol 2013; 167: 2149-2155.
2. Pande RL, Perlstein TS, Beckman JA, Creager MA,. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011; 124: 17-23.
3. Lehmacher W,. Kompetenzfeld "Peripheres arterielles Verschlussleiden (pAVK)" 2012 Available from: http://imsieweb.uni-koeln.de/lehre/kompetenzfelder/pavk/pavk.pdf. Last accessed April 5, 2014.
4. Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013; 382: 1329-1340.
5. Smolderen KG, Wang K, de Pouvourville G, Bruggenjurgen B, Rother J, Zeymer U, et al. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: Highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg 2012; 43: 198-207.
6. White CJ,. Non-surgical treatment of patients with peripheral vascular disease. Br Med Bull 2001; 59: 173-192.
7. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, et al. Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation 2008; 118: 1358-1365.
8. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012; 19: 1-9.
9. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-276.
10. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.
11. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011; 4: 495-504.
12. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: Twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther 2011; 18: 613-623.
13. Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: Evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 2012; 5: 831-840.
14. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther 2006; 13: 701-710.
15. Bosiers M, Torsello G, Gissler HM, Ruef J, Muller-Hulsbeck S, Jahnke T, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 2009; 16: 261-269.
16. Diehl SJ, Gerblich F, Jochum S, Huck K, Keese M, Schoenberg SO, et al. Twelve-month results of the EverFlex stent in the superficial femoral artery. J Vasc Interv Radiol 2012; 23: 1317-1322.
17. Banerjee S, Das TS, Abu-Fadel MS, Dippel EJ, Shammas NW, Tran DL, et al. Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: The COBRA Trial. J Am Coll Cardiol 2012; 60: 1352-1359.
18. Micari A, Cioppa A, Vadala G, Castriota F, Liso A, Marchese A, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv 2012; 5: 331-338.
19. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ, et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 2011; 54: 394-401.
20. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008; 358: 689-699.
21. Moreno R, Fernandez C, Sanchez-Recalde A, Galeote G, Calvo L, Alfonso F, et al. Clinical impact of in-stent late loss after drug-eluting coronary stent implantation. Eur Heart J 2007; 28: 1583-1591.
22. Contos B,. 2013 and Beyond: The Outlook forEndovascular Services. Endovasc Today 2013; 12: 28-40.
23. Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik) 2011-Operationen und Prozeduren der vollstationären Patientinnen und Patienten in Krankenhäusern bis zum kodierbaren Endpunkt. Wiesbaden: Statistisches Bundesamt.
24. Micari A, Cioppa A, Vadala G, Castriota F, Liso A, Marchese A, et al. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: Evidence from a multicenter registry. JACC Cardiovasc Interv 2013; 6: 282-289.
25. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-Year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 2013; 61: 2417-2427.